Immunopathogenesis and therapy of cutaneous T cell lymphoma
Authors:
- Ellen J. KimEKEllen J. Kim
- Stephen HessSHStephen Hess
- Stephen K. RichardsonSRStephen K. Richardson
- Sara NewtonSNSara Newton
- Louise C. ShoweLSLouise C. Showe
- Bernice M. BenoitBBBernice M. Benoit
- Ravi UbrianiRURavi Ubriani
- Carmela C. VittorioCVCarmela C. Vittorio
- Jacqueline M. Junkins-HopkinsJJJacqueline M. Junkins-Hopkins
- Maria WysockaMWMaria Wysocka
- Alain H. RookARAlain H. Rook
- 10 March 2005
- journal article
- Published by American Society for Clinical Investigation in Journal of Clinical Investigation
- Vol. 115 (4) , 798-812
Abstract
Cutaneous T cell lymphomas (CTCLs) are a heterogenous group of lymphoproliferative disorders caused by clonally derived, skin-invasive T cells. Mycosis fungoides (MF) and Sézary syndrome (SS) are the most common types of CTCLs and are characterized by malignant CD4+/CLA+/CCR4+ T cells that also lack the usual T cell surface markers CD7 and/or CD26. As MF/SS advances, the clonal dominance of the malignant cells results in the expression of predominantly Th2 cytokines, progressive immune dysregulation in patients, and further tumor cell growth. This review summarizes recent insights into the pathogenesis and immunobiology of MF/SS and how these have shaped current therapeutic approaches, in particular the growing emphasis on enhancement of host antitumor immune responses as the key to successful therapy.Keywords
This publication has 82 references indexed in Scilit:
- Clinicopathological spectrum of mycosis fungoidesJournal of the European Academy of Dermatology and Venereology, 2004
- The Pathogenesis of Mycosis FungoidesNew England Journal of Medicine, 2004
- Immune surveillance in the skin: mechanisms and clinical consequencesNature Reviews Immunology, 2004
- The Sézary syndrome: hematologic criteriaHematology/Oncology Clinics of North America, 2003
- Thymus and activation-regulated chemokine (TARC/CCL17) in mycosis fungoides: Serum TARC levels reflect the disease activity of mycosis fungoidesJournal of the American Academy of Dermatology, 2003
- Increased CCR4 Expression in Cutaneous T Cell LymphomaJournal of Investigative Dermatology, 2002
- Immune Surveillance and Effector Functions of CCR10+ Skin Homing T CellsThe Journal of Immunology, 2002
- The relevance of the CD4+ CD26- subset in the identification of circulating Sézary cellsBritish Journal of Dermatology, 2001
- Twenty-year trends in the reported incidence of mycosis fungoides and associated mortality.American Journal of Public Health, 1999
- Clinical stage IA (limited patch and plaque) mycosis fungoides. A long-term outcome analysisArchives of Dermatology, 1996